2003
DOI: 10.1590/s0036-46652003000600001
|View full text |Cite
|
Sign up to set email alerts
|

Cryptococcosis: a review of the brazilian experience for the disease

Abstract: SUMMARYCryptococcosis is a systemic mycosis caused by Cryptococcus neoformans. The disease occurs in patients with cellular immunodeficiency. The incidence of cryptococcosis arises with AIDS, and mycosis is one of the opportunistic infections that defines AIDS. After the HAART era the occurrence of cryptococcosis decreased all over the world, but it still continues to be a prevalent disease in Brazil. Thus, we consider this paper to be very important as a result of our reviewing of Brazilian literature regardi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
57
0
45

Year Published

2006
2006
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 91 publications
(104 citation statements)
references
References 49 publications
(60 reference statements)
2
57
0
45
Order By: Relevance
“…A review of cryptococcosis Brazilian experience was published in 2003 by PAPPALARDO & MELHEM 23 , showing the great importance of this disease for morbidity and mortality rates.…”
Section: Discussionmentioning
confidence: 99%
“…A review of cryptococcosis Brazilian experience was published in 2003 by PAPPALARDO & MELHEM 23 , showing the great importance of this disease for morbidity and mortality rates.…”
Section: Discussionmentioning
confidence: 99%
“…A epidemiologia da criptococose depende diretamente da espécie envolvida, sendo C. neoformans o principal causador da doença em indivíduos imunocomprometidos (Rodrigues et al 1999, Pappalardo & Melhem 2003. No entanto, C. gattii, além de afetar hospedeiros imunossuprimidos, causa a doença em indivíduos imunocompetentes (Duncan et al 2006).…”
Section: Introductionunclassified
“…Existem vários fatores que podem contribuir para ocorrência de falha terapêutica, assim como podem existir fenótipos resistentes à terapêutica empregada. Os fenótipos resistentes podem ser identificados em uma população contendo vários agentes etiológicos por meio de testes de susceptibilidade in vitro os quais podem ser realizados por vários métodos disponíveis no mercado 25 .…”
unclassified